Clinical Trial Update: Randomized Trial of Liposomal Amphotericin B for Histoplasmosis in AIDS Patients [Phase 2]

View source ↗

Summary

Phase 2 randomized trial results evaluate liposomal amphotericin B for histoplasmosis in patients with Acquired immune deficiency syndrome; the study completed …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Immune Deficiency Syndrome
• Histoplasmosis

Drugs mentioned

• AMBISOME (AMPHOTERICIN B)

Snippet

Sponsor: Alessandro Pasqualotto | Conditions: Histoplasmosis, AIDS | Phase 2 | Status: COMPLETED | Results posted: 2025-03-14